Evidence map›Paper›PMID 37080968›Full record

ArticleBlood cancer journal2023

Utility of flow cytometry screening before MRD testing in multiple myeloma.

Vandana Panakkal, Arjun Lakshman, Min Shi, Horatiu Olteanu, Pedro Horna, Michael M Timm, Gregory E Otteson, Linda B Baughn, Patricia T Greipp, Wilson I Gonsalves and 8 more

Open access · goldAbstract readLetter
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Vandana PanakkalDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Arjun LakshmanDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8915-2382
Min ShiDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Horatiu OlteanuDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5783-4485
Pedro HornaDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Michael M TimmDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Gregory E OttesonDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Linda B BaughnDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5229-4897
Patricia T GreippDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Wilson I GonsalvesDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Prashant KapoorDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4342-364X
Morie A GertzDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3853-5196
Moritz BinderDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-9014-9658
Francis K BuadiDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Angela DispenzieriDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8780-9512
S Vincent RajkumarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5862-1833
Shaji K KumarDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5392-9284
Dragan JevremovicDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA. Jevremovic.Dragan@mayo.edu.ORCID 0000-0002-1792-5822
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

Onset and biomarkers for progression of monoclonal gammopathiesR01CA168762 · NCI · MAYO CLINIC ROCHESTER · PI KUMAR, SHAJI KUNNATHU, RAJKUMAR, S VINCENT · 2012 to 2024
$3.2M
NCI NIH HHS R01 CA168762
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaFlow CytometryHumansNeoplasm, Residual

Identifiers

PMID37080968
PMCPMC10119092
OpenAlexW4366598889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.